O
Outlook Therapeutics, Inc.
Biotechnology · Iselin · United States · 11-50
0 followers
Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet age-related macular degeneration (wet AMD), diabetic macular edema (DME) and branch retinal vein occlusion (BRVO).
https://outlooktherapeutics.com ↗
Open jobs at Outlook Therapeutics, Inc.
No open jobs at the moment.